BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9797676)

  • 1. Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model.
    Reis A; Reinhard T; Sundmacher R; Braunstein C; Godehardt E
    Br J Ophthalmol; 1998 Jun; 82(6):700-3. PubMed ID: 9797676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative investigation of FK506 and cyclosporin A in murine corneal transplantation.
    Reis A; Reinhard T; Sundmacher R; Braunstein S; Godehardt E
    Graefes Arch Clin Exp Ophthalmol; 1998 Oct; 236(10):785-9. PubMed ID: 9801895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of the new macrolide immunosuppressant RAD and mycophenolate mofetil in experimental corneal transplantation.
    Reis A; Megahed M; Reinhard T; Godehardt E; Spelsberg H; Braunstein C; Sundmacher R
    Transplantation; 2000 Nov; 70(9):1397-401. PubMed ID: 11087159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial.
    Reis A; Reinhard T; Voiculescu A; Kutkuhn B; Godehardt E; Spelsberg H; Althaus C; Sundmacher R
    Br J Ophthalmol; 1999 Nov; 83(11):1268-71. PubMed ID: 10535855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of preoperative mycophenolate mofetil in murine corneal transplantation.
    Reis A; Spelsberg H; Reinhard T; Braunstein S; Godehardt E; Sundmacher R
    Transpl Int; 1999; 12(5):341-5. PubMed ID: 10551999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of mycophenolate mofetil on endothelial function in an aortic allograft model.
    Fréguin-Bouilland C; Godin M; Bellien J; Richard V; Remy-Jouet I; Dautreaux B; Henry JP; Compagnon P; Thuillez C; Plissonnier D; Joannidès R
    Transplantation; 2011 Jan; 91(1):35-41. PubMed ID: 21441851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of mycophenolate sodium (MPS) and mycophenolate mofetil (MMF) with and without cyclosporine in rat transplantation models.
    Schuurman HJ; Pally C; Fringeli-Tanner M; Papageorgiou C
    Transplantation; 2001 Dec; 72(11):1776-83. PubMed ID: 11740387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.
    Noris M; Azzollini N; Pezzotta A; Mister M; Benigni A; Marchetti G; Gagliardini E; Perico N; Remuzzi G
    J Am Soc Nephrol; 2001 Sep; 12(9):1937-1946. PubMed ID: 11518788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression.
    du Toit D; Muller C; Page B; Louw J
    Microsc Res Tech; 1998 Nov; 43(4):347-55. PubMed ID: 9849976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
    Tsai MK; Hu RH; Lee CJ; Lee PH
    J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
    Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental efficacy of mycophenolate mofetil implant on high-risk corneal allograft rejection and its biocompatibility in the anterior chamber of rabbits.
    Xin M; Wang T; Shi W; Wu X
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):609-17. PubMed ID: 22846154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial.
    Åsberg A; Apeland T; Reisaeter AV; Foss A; Leivestad T; Heldal K; Thorud LO; Eriksen BO; Hartmann A;
    Clin Transplant; 2013; 27(2):E151-6. PubMed ID: 23351013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
    Jolicoeur EM; Qi S; Xu D; Dumont L; Daloze P; Chen H
    Transplantation; 2003 Jan; 75(1):54-9. PubMed ID: 12544871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
    Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.
    Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C
    J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
    Wang J; Song X; Zhang W; Tong S; Hou J; Chen L; Lou J; Li H; Ding X; Min B
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):507-10. PubMed ID: 12133492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.